# Sequential CD19-targeted chimeric antigen receptor T cell therapy and azacitidine with venetoclax for relapsed mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report

**Authors:** 晓嘉 郭, 漾 杨, 高翔 王, 阳 曹, 晓霞 胡, 传和 江

PMC · DOI: 10.3760/cma.j.cn121090-20241203-00528 · Chinese Journal of Hematology · 2025-05-01

## Full-text entities

- **Genes:** CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}
- **Diseases:** acute leukemia (MESH:D015470)
- **Chemicals:** venetoclax (MESH:C579720), azacitidine (MESH:D001374), chimeric antigen receptor T (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12268289/full.md

---
Source: https://tomesphere.com/paper/PMC12268289